Boundless Bio, Inc. (BOLD)
(Delayed Data from NSDQ)
$3.85 USD
+0.04 (1.05%)
Updated Jul 31, 2024 04:00 PM ET
After-Market: $3.84 -0.01 (-0.26%) 7:56 PM ET
2-Buy of 5 2
F Value D Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for Boundless Bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -49.43 | -45.90 | NA | NA | NA |
Depreciation/Amortization & Depletion | 0.96 | 0.94 | NA | NA | NA |
Net Change from Assets/Liabilities | -0.80 | 0.87 | NA | NA | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | NA | NA | NA |
Other Operating Activities | 2.42 | 4.50 | NA | NA | NA |
Net Cash From Operating Activities | -46.86 | -39.60 | NA | NA | NA |
Property & Equipment | -0.63 | -1.07 | NA | NA | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | NA | NA | NA |
Investments | -37.63 | 17.20 | NA | NA | NA |
Other Investing Activities | 0.00 | 0.00 | NA | NA | NA |
Net Cash from Investing Activities | -38.26 | 16.13 | NA | NA | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 99.85 | 0.13 | NA | NA | NA |
Issuance (Repayment) of Debt | 0.00 | 0.00 | NA | NA | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | NA | NA | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | NA | NA | NA |
Other Financing Activities | -1.96 | 0.00 | NA | NA | NA |
Net Cash from Financing Activities | 97.90 | 0.13 | NA | NA | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | NA | NA | NA |
Net Change In Cash & Equivalents | 12.78 | -23.34 | NA | NA | NA |
Cash at Beginning of Period | 11.48 | 34.82 | NA | NA | NA |
Cash at End of Period | 24.27 | 11.48 | NA | NA | NA |
Diluted Net EPS | -40.65 | NA | NA | NA | NA |
Fiscal Year End for Boundless Bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -15.43 | -49.43 | NA | NA |
Depreciation/Amortization & Depletion | NA | 0.26 | 0.96 | NA | NA |
Net Change from Assets/Liabilities | NA | -1.58 | -0.80 | NA | NA |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | NA | NA |
Other Operating Activities | NA | 0.97 | 2.42 | NA | NA |
Net Cash From Operating Activities | NA | -15.78 | -46.86 | NA | NA |
Property & Equipment | NA | -0.08 | -0.63 | NA | NA |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | NA | NA |
Investments | NA | 18.22 | -37.63 | NA | NA |
Other Investing Activities | NA | 0.00 | 0.00 | NA | NA |
Net Cash from Investing Activities | NA | 18.14 | -38.26 | NA | NA |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.06 | 99.85 | NA | NA |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | NA | NA |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | NA | NA |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | NA | NA |
Other Financing Activities | NA | -0.98 | -1.96 | NA | NA |
Net Cash from Financing Activities | NA | -0.92 | 97.90 | NA | NA |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | NA | NA |
Net Change In Cash & Equivalents | NA | 1.44 | 12.78 | NA | NA |
Cash at Beginning of Period | NA | 24.27 | 11.48 | NA | NA |
Cash at End of Period | NA | 25.70 | 24.27 | NA | NA |
Diluted Net EPS | NA | -12.27 | NA | NA | NA |